Effects of tranilast and pentoxifylline in a mouse model of chronic asthma using house dust mite antigen

Journal of Asthma

Volumn 46, Issue 9, 2009, Pages 884-894

  Kim, Seung Joon ^a   Kim, Jin Woo ^a   Kim, Yong Hyun ^a   Lee, Sang Haak ^a   Yoon, Hyoung Kyu ^a   Kim, Chi Hong ^a   Ahn, Joong Hyun ^a   Lee, Jung Mi ^a   Kim, Jin Sook ^a   Kim, Seok Chan ^a   Lee, Sook Young ^a   Kwon, Soon Seog ^a   Kim, Young Kyoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Asthma; House dust mite; Mouse; Pentoxifylline; Tranilast

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; PENTOXIFYLLINE; TRANILAST; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN SYNTHESIS INHIBITION; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; TH2 CELL; TRICHOME;

ANIMALS; ANTHRANILIC ACIDS; ANTI-ALLERGIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIOLES; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; FIBRILLAR COLLAGENS; GOBLET CELLS; HYPERPLASIA; IMMUNOGLOBULIN E; INTERLEUKIN-13; LEUKOCYTES; MICE; MICE, INBRED BALB C; MUSCLE, SMOOTH; PENTOXIFYLLINE; PULMONARY FIBROSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70449631643     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903089998     Document Type: Article

References (29)

1. Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol 2005; 116:477-486; quiz 487.
2. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to housedust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323:502-507.
3. Arlian LG, Platts-Mills TA. The biology of dustmites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol 2001; 107:S406- 413.
4. Azuma H, Banno K, Yoshimura T. Pharmacological properties of N-(3-,4-- dimethoxycinnamoyl) anthranilic acid (N-5-), a new anti-atopic agent. Br J Pharmacol 1976; 58:483-488.
5. Zampini P, Riviera AP, Tridente G. In vitro inhibition of histamine release from mouse mast cells and human basophils by an anthranilic acid derivative. Int J Immunopharmacol 1983; 5:431-435.
6. Koda A,KurashinaY,Nakazawa M. The inhibitionmechanism of histamine release by N-(3,4-dimethoxycinnamoyl) anthranilic acid. Int Arch Allergy Appl Immunol 1985; 77:244-245.
7. Nishigaki T. Mast cell degranulation and its inhibition by an anti-allergic agent tranilast. An electron microscopic study.VirchowsArch B Cell Pathol Incl Mol Pathol 1988; 55:311-322.
8. Isaji M, Nakajoh M, Naito J. Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5-) in granulation tissue. Biochem Pharmacol 1987; 36:469-474.
9. Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujiie A. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 1995; 118:213-221.
10. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994; 30:603-621.
11. Rott O, Cash E, Fleischer B. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 1993; 23:1745-1751.
12. Benbernou N, Esnault S, Potron G, Guenounou M. Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol 1995; 25 (suppl 2):S75-79.
13. Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 1997; 91:197-203.
14. Fujimoto T, Nakamura T, Furuya T, Nakane S, Shirabe S, Kambara C, Hamasaki S, Yoshimura T, Eguchi K. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy. Intern Med 1999; 38:717-721.
15. Fleming CM, He H, Ciota A, Perkins D, Finn PW. Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. J Immunol 2001; 167:1703-1711.
16. Padrid P, Snook S, Finucane T, Shiue P, Cozzi P, Solway J, Leff AR. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151:184-193.
17. Ikeda H, InaoM, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 1996; 227:322-327.
18. Yamada H, Tajima S, Nishikawa T. Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage culture. J Dermatol Sci 1995; 9:45-47.
19. Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krum H, Wilkinson-Berka J, Gilbert RE. Tranilast attenuates cardiac matrix deposition in experimental diabetes: Role of transforming growth factor-beta. Cardiovasc Res 2005; 65:694-701.
20. Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA. Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 2006; 69:989-995.
21. Oshima T, Kurosaka D, Kato K, Kurosaka H, Mashima Y, Tanaka Y, Tajima S. Tranilast inhibits cell proliferation and collagen synthesis by rabbit corneal and Tenon's capsule fibroblasts. Curr Eye Res 2000; 20:283-286.
22. Gopalan R, Goldberg S. Tranilast in the Therapy of Coronary Artery Disease. Curr Interv Cardiol Rep 2000; 2:149-156.
23. Soma J, Sato K, Saito H, Tsuchiya Y. Effect of tranilast in earlystage diabetic nephropathy. Nephrol Dial Transplant 2006; 21:2795-2799.
24. Entzian P, Bitter-Suermann S, Burdon D, Ernst M, Schlaak M, Zabel P. Differences in the anti-inflammatory effects of theophylline and pentoxifylline: Important for the development of asthma therapy? Allergy 1998; 53:749-754.
25. Lauterbach R, Pawlik D, Zembala M, Szymura-Oleksiak J, Lisowska- Miszczyk I, Kowalczyk D, Bury J. Pentoxyfylline in and prevention and treatment of chronic lung disease. Acta Paediatr Suppl 2004; 93:20-22.
26. McGee HS, Agrawal DK. TH2 cells in the pathogenesis of airway remodeling: Regulatory T cells a plausible panacea for asthma. Immunol Res 2006; 35:219-232.
27. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax 2005; 60:529-530.
28. Peters-Golden M. The alveolar macrophage: The forgotten cell in asthma. Am J Respir Cell Mol Biol 2004; 31:3-7.
29. Entzian P, Zahringer U, Schlaak M, Gerlach C, Galle J, Zabel P. Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis. Int J Immunopharmacol 1998; 20:723-735.